Gambling: Clinical Trials

4 trials for Gambling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Gambling: new trials by email Literature Review of Gambling trials Research Report on Gambling

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles
questionnaires - Parkinson's Disease, Secondary Behavioural Addiction
Phase 4CompletedNantes University Hospital2252012-10-012018-02-15
Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention
Naltrexone pharmacotherapy, Placebo - Pathological Gambling
Phase 4CompletedFinnish Institute for Health and Welfare1002011-01-012013-12-05
Naltrexone for Impulse Control Disorders in Parkinson's Disease
Naltrexone, Placebo - Impulse Control Disorder, Parkinson Disease
Phase 4CompletedUniversity of Pennsylvania502009-11-012015-08-06
Acamprosate in the Treatment of Pathological Gambling
acamprosate - Pathological Gambling
Phase 4CompletedUniversity of Iowa262007-10-012017-05-25

Narrower conditions

Disruptive, Impulse Control, and Conduct Disorders (2)  ·  Parkinson Disease (2)  ·  Compulsive Sexual Behavior Disorder (1)  ·  Food Addiction (1)

Broader conditions

Behavior (4)  ·  Mental Disorders (4)  ·  Risk-Taking (4)  ·  Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Disruptive, Impulse Control, and Conduct Disorders (2)  ·  Movement Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Parkinsonian Disorders (2)  ·  Synucleinopathies (2)  ·  Behavior, Addictive (1)  ·  Compulsive Behavior (1)  ·  Feeding and Eating Disorders (1)

Interventions

Acamprosate (1)  ·  Naltrexone (1)  ·  Surveys and Questionnaires (1)  ·  vivitrol (1)

Sponsors

Finnish Institute for Health and Welfare (1)  ·  Nantes University Hospital (1)  ·  University of Iowa (1)  ·  University of Pennsylvania (1)

Countries

Finland (1)  ·  France (1)  ·  United States (1)

Top investigators

Daniel Weintraub, MD (1)  ·  Dennis P McNeilly, PsyD (1)  ·  Donald W Black, MD (1)  ·  Hannu Alho, Professor (1)  ·  Tuuli Lahti, Adjunct Professor (1)

Results publications

PMID 25037206, PMID 26339899, PMID 36130734